Dr. David Glass, M.D.
Executive Director, Age Related Disorders and Pathways
Novartis Institutes for BioMedical Research
“Mechanisms mediating skeletal muscle mass, function and aging”
Dr. David J. Glass has been the Executive Director and Global Head of Muscle Diseases research at Novartis Institutes for BioMedical Research since 2005. In 2014 he started a new group aimed at investigating Age-Related Disorders, studying signaling pathways that are perturbed by age, so as to create a permissive or causative environment for disease. Born and raised in New York City, Dr. Glass received his undergraduate degree from Columbia University and his M.D. from New York Medical College. After postdoctoral work at Columbia, he worked at Regeneron Pharmaceuticals for 14 years, where he became a Vice President, before establishing the Muscle Diseases group at Novartis. The first clinical candidate from his group to reach the clinic was granted “Breakthrough Therapy” status by the FDA for the treatment of Sporadic Inclusion Body Myositis.
Friday, April 28 2017
4:00 pm to 5:00 pm
Michael Smith Laboratories (Room 102 – Lecture Theatre)
2185 East Mall
Vancouver, BC
Hosted by Dr. Fabio Rossi
fabio@brc.ubc.ca